Wytech Industries12.02.20
Wytech Industries, a portfolio company of Vance Street Capital, and a leader in the design and manufacture of complex specialty core wires and precision wire components for a wide range of advanced guidewires and delivery systems has announced their talented team is expanding with the addition of Henry Burmeister as chief financial officer. With the recent acquisition by Vance Street Capital, Wytech has added resources to acquire and advance into new technologies and to fortify its existing manufacturing platform.
Burmeister has a strategic finance and operational background in medical device contract manufacturing which complements Wytech’s existing leadership & manufacturing teams that support product development within interventional and orthopedic markets. Burmeister has held various leadership roles focusing in medical device contract manufacturing, design/ development, and specialty chemicals. Most recently, serving as Viant Medical’s VP Finance, Operations. Prior to Viant, he led Vention Medical’s acquisition & integration strategy before acquisition by Nordson Medical in 2017.
“Henry’s significant strategic and operational experience will complement Wytech’s existing operations & management team well,” said Mike Casalino, CEO. “Our team is eager to leverage Henry’s expertise and welcome him to the Wytech family as we continue to focus on manufacturing world class medical device components.”
Burmeister has a strategic finance and operational background in medical device contract manufacturing which complements Wytech’s existing leadership & manufacturing teams that support product development within interventional and orthopedic markets. Burmeister has held various leadership roles focusing in medical device contract manufacturing, design/ development, and specialty chemicals. Most recently, serving as Viant Medical’s VP Finance, Operations. Prior to Viant, he led Vention Medical’s acquisition & integration strategy before acquisition by Nordson Medical in 2017.
“Henry’s significant strategic and operational experience will complement Wytech’s existing operations & management team well,” said Mike Casalino, CEO. “Our team is eager to leverage Henry’s expertise and welcome him to the Wytech family as we continue to focus on manufacturing world class medical device components.”
